I strongly suggest that people read section 7 of the prospective, where they outlined all of the risks present. From having read it myself, I believe it is almost impossible that SAS would be able to build and launch the first batch, let alone generate revenue in 2019. If such scenario is true then SAS would need to do another CR, which I do not think SAS would be able to manage to pull off. Read section 7 yourself and try to figure out how much fund would be needed and see what you think.
I think the risk is just so gargantuan now.
SAS Price at posting:
3.2¢ Sentiment: Sell Disclosure: Not Held